QIAGEN’s GeneReader NGS System delivers accuracy and ease of use for clinical research in oncology

Hilden, Germany, and Germantown, Maryland, November 14, 2017 – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced new studies highlighting the outstanding analytical performance and ease of use of the GeneReader NGS System, the world’s first complete Sample to Insight solution for next-generation sequencing. The studies are being presented this week at the... Read more

Leading Pathologists to Showcase First Case Studies with Oncomine Dx Target Test at Association for Molecular Pathology Annual Meeting

Leading Pathologists to Showcase First Case Studies with Oncomine Dx Target Test at Association for Molecular Pathology Annual Meeting Thermo Fisher Scientific customers also highlight their latest research advancements in solid tumor profiling and liquid biopsy analysis during corporate workshops CARLSBAD, Calif. and SALT LAKE CITY, Nov. 14, 2017 /PRNewswire/ — Advances in next-generation sequencing (NGS)... Read more

SCIEX Announces Joint Venture With Zhenjang Dian Diagnostics in China

Leading Diagnostics Companies Combine to Address Diagnostic and Wellness Testing in China November 13, 2017 04:00 AM Pacific Standard Time FRAMINGHAM, Mass. & SHANGHAI–(BUSINESS WIRE)–SCIEX Diagnostics, the in vitro diagnostics (IVD) division of SCIEX, a global leader in mass spectrometry in the life sciences industry, announced today that it has formed a joint venture (JV) with Zhejiang... Read more

Beckman Coulter Diagnostics Receives CE Mark Clearance for its High-sensitivity Access hsTnI Assay

New assay enables hospitals to provide efficiency improvements in cardiac patient management BREA, CALIF. — (Nov 7, 2017) — Beckman Coulter Diagnostics announced today that it has received CE Mark clearance for a new high-sensitivity troponin (hsTnI) assay that aids in diagnosing myocardial infarction for patients presenting with chest pain or other ischemic symptoms. “The new,... Read more

Elsevier and Seven Bridges Receive NIH Data Commons Grant for Biomedical Data Analysis

Project to improve biomedical data efficiency and reliability NEW YORK, November 7, 2017 /PRNewswire/ — Elsevier and Seven Bridges Genomics announced today that The National Institutes of Health (NIH) has awarded them a grant for the development of a comprehensive, open-source data analysis ecosystem as part of its Data Commons Pilot Phase. The project is designed to improve data efficiency and reliability for... Read more

Seven Bridges Leads Public-Private Partnership to Develop New Data Ecosystem for NIH

November 6, 2017 Consortium will build cloud-based data resources, tools, and interoperable standards, giving researchers simultaneous access to biomedical datasets from across the National Institutes of Health CAMBRIDGE, Mass., November 06, 2017 – Seven Bridges, the leading biomedical data analysis company, today announced that it has been selected by the National Institutes of Health (NIH) to support... Read more

American Association of Clinical Chemistry

31. July 2018 – 03. August 2018 Visit Greiner Bio-One at booth 1440 at the AACC! JOIN THE GLOBAL LABORATORY MEDICINE COMMUNITY The 70th AACC Annual Scientific Meeting & Clinical Lab Expo is the largest global scientific conference and tradeshow in the field of laboratory medicine. At this dynamic meeting, you’ll have the opportunity to:... Read more